CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −5,500 | 5,500 | ||
| 2026-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −3,333 | 6,667 | ||
| 2026-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −6,667 | 0 | ||
| 2026-01-31 | Smith Jason Drew General Counsel | Grant or award · Restricted Stock Units | +32,609 | 32,609 | ||
| 2026-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +3,333 | 145,692 | ||
| 2026-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +6,666 | 152,358 | ||
| 2026-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +3,334 | 142,359 | ||
| 2026-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −3,333 | 3,334 | ||
| 2026-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −6,666 | 13,334 | ||
| 2026-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −3,334 | 0 | ||
| 2026-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2026-01-31 | Degnan Chris Chief Financial Officer | Grant or award · Restricted Stock Units | +32,609 | 32,609 | ||
| 2025-11-26 | Holden Stuart Director | Option exercise | +2,000 | 2,000 | ||
| 2025-11-26 | Holden Stuart Director | Option exercise · Restricted Stock Unit | −2,000 | 6,000 | ||
| 2025-11-26 | BUTITTA CYNTHIA M Director | Option exercise | +2,000 | 2,000 | ||
| 2025-11-26 | BUTITTA CYNTHIA M Director | Option exercise · Restricted Stock Unit | −2,000 | 6,000 | ||
| 2025-11-26 | Robinson James A. Jr. Director | Option exercise | +2,000 | 2,000 | ||
| 2025-11-26 | Robinson James A. Jr. Director | Option exercise · Restricted Stock Unit | −2,000 | 6,000 | ||
| 2025-11-26 | WEN LEANA Director | Option exercise | +2,000 | 2,000 | ||
| 2025-11-26 | WEN LEANA Director | Option exercise · Restricted Stock Unit | −2,000 | 6,000 |
Page 3 of 13 · 244 trades